Translational enhancement by base editing of the Kozak sequence rescues haploinsufficiency
Authors:
- Chiara AmbrosiniCAChiara Ambrosini
- Eliana DestefanisEDEliana Destefanis
- Eyemen KheirEKEyemen Kheir
- Francesca BrosoFBFrancesca Broso
- Federica AlessandriniFAFederica Alessandrini
- Sara LonghiSLSara Longhi
- Nicolò BattistiNBNicolò Battisti
- Erik DassiEDErik Dassi
- Gianluca PetrisGPGianluca Petris
- Anna CeresetoACAnna Cereseto
- Alessandro QuattroneAQAlessandro Quattrone
Open Access
- 27 September 2022
- journal article
- research article
- Published by Oxford University Press (OUP) in Nucleic Acids Research
- Vol. 50 (18) , 10756-10771
Abstract
A variety of single-gene human diseases are caused by haploinsufficiency, a genetic condition by which mutational inactivation of one allele leads to reduced protein levels and functional impairment. Translational enhancement of the spare allele could exert a therapeutic effect. Here we developed BOOST, a novel gene-editing approach to rescue haploinsufficiency loci by the change of specific single nucleotides in the Kozak sequence, which controls translation by regulating start codon recognition. We evaluated for translational strength 230 Kozak sequences of annotated human haploinsufficient genes and 4621 derived variants, which can be installed by base editing, by a high-throughput reporter assay. Of these variants, 149 increased the translation of 47 Kozak sequences, demonstrating that a substantial proportion of haploinsufficient genes are controlled by suboptimal Kozak sequences. Validation of 18 variants for 8 genes produced an average enhancement in an expression window compatible with the rescue of the genetic imbalance. Base editing of the NCF1 gene, whose monoallelic loss causes chronic granulomatous disease, resulted in the desired increase of NCF1 (p47phox) protein levels in a relevant cell model. We propose BOOST as a fine-tuned approach to modulate translation, applicable to the correction of dozens of haploinsufficient monogenic disorders independently of the causing mutation.Keywords
Funding Information
- Ogni giorno per Emma
- Sorriso di Ilaria di Montebruno
- Enrico and Ivana Zobele
- Marie Skłodowska-Curie (897663)
- European Regional Development Fund
This publication has 67 references indexed in Scilit:
- Gene Expression Regulation by Upstream Open Reading Frames and Human DiseasePLOS Genetics, 2013
- CAS9 transcriptional activators for target specificity screening and paired nickases for cooperative genome engineeringNature Biotechnology, 2013
- The N‐end rule pathway and regulation by proteolysisProtein Science, 2011
- Characterising and Predicting Haploinsufficiency in the Human GenomePLOS Genetics, 2010
- A copy number variation in human NCF1 and its pseudogenesBMC Genetics, 2010
- Identification of human haploinsufficient genes and their genomic proximity to segmental duplicationsEuropean Journal of Human Genetics, 2008
- PTC124 is an orally bioavailable compound that promotes suppression of the human CFTR -G542X nonsense allele in a CF mouse modelProceedings of the National Academy of Sciences, 2008
- Diversity of preferred nucleotide sequences around the translation initiation codon in eukaryote genomesNucleic Acids Research, 2007
- A C/T Single-Nucleotide Polymorphism in the Region of the CD40 Gene is Associated with Graves' DiseaseThyroid®, 2002
- Ataxia caused by mutations in the alpha -tocopherol transfer protein geneJournal of Neurology, Neurosurgery & Psychiatry, 2000